Neurizon Therapeutics (ASX:NUZ) Price-to-Tangible-Book : 4.17 (As of Apr. 14, 2025)

Neurizon Therapeutics Price-to-Tangible-Book Chart

Neurizon Therapeutics Semi-Annual Data
	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Jun24	Dec24
Price-to-Tangible-Book	Get a 7-Day Free Trial															6.25	4.27	9.58	8.48	7.08

Competitive Comparison of Neurizon Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Neurizon Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurizon Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurizon Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Neurizon Therapeutics's Price-to-Tangible-Book falls into.

Neurizon Therapeutics Price-to-Tangible-Book Calculation

Neurizon Therapeutics's price-to-tangible-book ratio for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Neurizon Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurizon Therapeutics Business Description